Fear of hypoglycemia in adults with diabetes mellitus switching to treatment with IDegAsp co-formulation to examine real-world setting: an observational study (The HATICE study).
Ulaş Serkan TopaloğluHatice Kayış TopaloğluMelih KızıltepeMesut KılıçSami BahçebaşıSibel AtaŞeyma YıldızYasin ŞimşekPublished in: Drug metabolism and personalized therapy (2020)
IDegAsp co-formulation, combined with DPP4-i and/or SGLT2-i, can provide usefulness in terms of rates of hypoglycemia, reduced HbA1c, less injection administration, and decreased the fear of hypoglycemia in diabetics.